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Introduction 
Stem cells are cells that can differentiate into more specialized cells.  Of the two types of 
stem cells, embryonic stem cells and adult stem cells, embryonic stem cells are believed to be 
more pluripotent, meaning they are able to differentiate into more types of cells than adult stem 
cells.  Due to this characteristic, embryonic stem cells are believed to have the potential to treat a 
number of diseases, including cancer and spinal cord injuries.  Two main controversies lie in the 
acquisition of embryonic stem cells:  the destruction of the blastocyst and the issue of therapeutic 
cloning. 
When an egg and a sperm fuse, a zygote is formed that undergoes cleavages until the cell 
count reaches approximately 150 cells, at which point this early embryo is called a blastocyst 
(Bailey, 2001).  To be used in research, embryonic stem cells must be extracted from the 
blastocyst, causing its destruction.  The debate here is in whether it is acceptable to take the 
“life” of the embryo to potentially cure diseases and save future lives.  Those who approve are 
then asked if this is acceptable to do only to excess blastocysts created in fertility clinics, 
destined to be destroyed anyways, or if it is acceptable to create new blastocysts for a purpose 
which will ultimately lead to their destruction. 
In addition to in vitro fertilization, embryonic stem cells can be obtained through 
therapeutic cloning.  Research is currently focused on the somatic cell nuclear transfer method, 
which produces embryonic stem cells that have the exact same genetic composition as the 
nuclear donor.  Some believe that this type of cloning should be banned, citing moral reasons, 
and others believe that it is acceptable as long as the blastocyst is never implanted into a uterus 
and carried to term (reproductive cloning).  Obtaining eggs from donors for this type of cloning 
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is also controversial because the extraction procedure is invasive and can cause a number of 
complications (Beeson, 2006). 
 The basis for the ethical dilemmas surrounding embryonic stem cells hinges upon the 
assumption that embryonic stem cells are “better” than the much less controversial and adult 
stem cells.  and adult stem cells have been in the shadow of embryonic stem cells due to the 
numerous political debates and media reports centered on the embryonic stem cells issue.  It may 
be easy for healthcare providers to favor embryonic stem cells research due to this publicity in 
conjunction with the concept of beneficence.  The purpose of this paper is to educate healthcare 
providers on the often overlooked research behind and adult stem cells vs. embryonic stem cells.  
Healthcare providers should be well informed of the science that can influence their political 
stance on stem cells due to the possible clinical ramifications of their political views. 
Review of Literature 
 Embryonic stem cells have commonly been believed to be more pluripotent than adult 
stem cells.  However, new research shows that adult stem cells are more like embryonic stem 
cells in terms of differentiation potential than previously thought.  For example, Schultz and 
Lucas (2006) showed that adult muscle stem cells can change into nerve cells.  Four sources of 
adult stem cells that have shown promise as alternatives to embryonic stem cells include 
olfactory cells, bone marrow cells, placental cells, and umbilical cord cells.  A study by Murrell 
et al. (2005) demonstrated how adult olfactory cells can generate muscle, kidney, heart, liver, 
brain and nerve cells.  In a study by Crain, Tran, and Mezey (2005), bone marrow stem cells 
from male donors were transplanted into females.  The Y chromosomes of these cells were 
tagged so that they could be traced.  The tagged Y chromosomes were found in various neurons 
in different parts of the brain, in both white and grey matter.  Miki, Lehmann, Cai, Stolz, and 
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Strom (2005) showed that amniotic epithelial cells could generate cells of all three germ layers 
(endoderm, mesoderm, and ectoderm) just like embryonic stem cells.  These cells also displayed 
low tumor tendency, a common problem in embryonic stem cells.   In a study by Xiao, Nan, 
Motooka, and Low (2005), rats that had suffered ischemic strokes were injected with either non-
hematopoetic umbilical cord blood stem cells (nh-UCBSCs) or saline (control).  Those receiving 
nh-UCBSCs later performed significantly better on behavioral tests and showed a 50% reduction 
in lesion volume compared to the control.  All of these four types of adult stem cells are easily 
accessible and do not require egg harvesting, cloning, or destruction of blastocysts. 
 There is some evidence to support the idea that adult stem cells are therapeutically more 
effective than embryonic stem cells.  Prentice (2006) lists 72 diseases in which adult stem cells 
adult stem cells have shown benefits in human clinical trials, versus zero for embryonic stem 
cells.  Three diseases in which adult stem cells research will be compared to embryonic stem 
cells research are: spinal cord injuries, diabetes, and Parkinson’s disease. 
 In a recent pilot clinical study(Lima et al., 2006), seven patients with traumatic spinal 
cord injuries were given olfactory mucosa autografts containing adult stem cells onto the area of 
their lesions.  MRIs showed that the lesions were moderately to completely filled in all seven 
patients.  All seven patients had improvements on both motor and sensory test scores.  Two 
regained bladder sensation, one of which also regained voluntary anal sphincter control.  
Deshpande et al., (2006) performed a similar embryonic stem cell study on rats paralyzed by 
spinal cord injuries.  The rats regained partial mobility, but the success of the transplanted 
embryonic stem cell-derived axons relied heavily on the presence of a growth factor produced by 
adult neural stem cells  
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 To study the potential use of adult stem cells in diabetes, Yoshida et al. (2005) 
transplanted human umbilical cord blood stem cells into insulin-dependent diabetic mice.  The 
result was that these adult stem cells generated insulin producing cells in the pancreatic tissue of 
the mice, reversing their condition.  Recent diabetes studies using embryonic stem cells have not 
been as successful.  Insulin-like cell clusters, embryonic stem cells that resemble islet-cells, were 
found to not have the ability to produce insulin—they could only regurgitate exogenously added 
insulin (Paek, Moise, Morgan, & Lysaght, 2005).  Fujikawa et al., (2005) was successful in 
reversing Type 1 diabetes in mice using insulin-secreting cells derived from embryonic stem 
cells, however, the results lasted only three weeks due to tumor development secondary to the 
treatment.   
 Stem cell research in Parkinson’s has yielded similar results.  In 2006, Weiss et al. tested 
the therapeutic value of human umbilical cord stem cells from Wharton’s jelly.  These cells, 
called umbilical cord matrix stem cells, were transplanted into the brains of rats with 
Parkinson’s, resulting in significant improvements in motion and behavior.  In another research 
study, Brederlau et al., (2006) differentiated human embryonic stem cells into dopamine neurons 
in vitro for 16, 20, or 23 days, and then transplanted them into mice with Parkinson’s.  No 
alleviation of symptoms was found with any of the three groups, and the group that received the 
embryonic stem cells that were predifferentiated for only 16 days developed tumors. 
 In looking at the stem cells issue from the perspective of adult stem cells as equal or 
better alternatives than embryonic stem cells, the ethical issues shift from those of embryo 
destruction and cloning to those of resources and politics.  Regardless of one’s moral values in 
regard to embryo destruction or cloning, one may still face a dilemma when considering whether 
or not to endorse embryonic stem cells.  For example, by voting for government funding of 
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embryonic stem cells research, one may unknowingly be propagating the use of tax dollars on 
research that is less promising than adult stem cells research.  In the November 2006 Missouri 
elections, the pro- embryonic stem cells Amendment No. 2 won by a narrow 51.2% to 48.8% 
vote (Carnahan, 2006). The campaign’s tag line, “It could save the life of someone you love,” 
has been criticized for implying that cures from embryonic stem cells were imminent (Wagar, 
2006).   
Conclusion 
 In summary, the controversies regarding embryonic stem cells are issues in which pros 
and cons are weighed.  It seems that the possibility that adult stem cells have more pros and 
fewer cons than embryonic stem cells has been overlooked amidst the embryonic stem cells 
debate.  Compared to embryonic stem cells, adult stem cells also produce all three germ layers, 
but require no egg harvesting, cloning, or destruction of blastocysts, and are less tumorogenic.  
Adult stem cells research accounts for all clinical trials in humans and has shown more promise 
in key diseases. 
 One major flaw in the argument that adult stem cells are better than embryonic stem cells 
is that research on adult stem cells has been conducted for a much longer time than on embryonic 
stem cells.  It is not fair to compare the advancements in each field when one field has had twice 
the amount of time to develop than the other.  However, embryonic stem cells skeptics say that 
even if more time and funding was given to embryonic stem cells research than adult stem cells 
research, the public’s high expectations of “miracle cures” would still be impossible to reach.  I 
believe that with today’s technological advancements, it would be foolish to say what will 
always be impossible.  This is why I do believe in embryonic stem cells research.  But I also 
believe in adult stem cells research just as much, and would think twice before voting on laws 
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that may allocate more money to embryonic stem cells research than adult stem cells research.  
Why pour time resources into a new field that is still in its infancy stages and is shrouded by 
legal and ethical controversy when a field that is on the brink of major breakthroughs already 
exists?   
Healthcare providers should be informed on current healthcare issues in order to make 
informed decisions in the political realm. This is a professional responsibility of a nurse.  And to 
become well informed on controversial issues, one must look at both sides with an eager, open 
mind.  As stem cells continue to be one of the major issues in biomedical research, my 
knowledge will allow me to provide others with complete and accurate information on the topic.
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